Exosome Release Is Modulated by the Mitochondrial-Lysosomal Crosstalk in Parkinson's Disease Stress Conditions

Mol Neurobiol. 2021 Apr;58(4):1819-1833. doi: 10.1007/s12035-020-02243-3. Epub 2021 Jan 6.

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra (SN) pars compacta region of the brain. The main pathological hallmark involves cytoplasmic inclusions of α-synuclein and mitochondrial dysfunction, which is observed in other part of the central nervous system other than SN suggesting the spread of pathogenesis to bystander neurons. The inter-neuronal communication through exosomes may play an important role in the spread of the disease; however, the mechanisms are not well elucidated. Mitochondria and its role in inter-organellar crosstalk with multivesicular body (MVB) and lysosome and its role in modulation of exosome release in PD is not well understood. In the current study, we investigated the mitochondria-lysosome crosstalk modulating the exosome release in neuronal and glial cells. We observed that PD stress showed enhanced release of exosomes in dopaminergic neurons and glial cells. The PD stress condition in these cells showed fragmented network and mitochondrial dysfunction which further leads to functional deficit of lysosomes and hence inhibition of autophagy flux. Neuronal and glial cells treated with rapamycin showed enhanced autophagy and inhibited the exosomal release. The results here suggest that maintenance of mitochondrial function is important for the lysosomal function and hence exosomal release which is important for the pathogenesis of PD.

Keywords: Exosome release; Mitochondria-lysosome crosstalk; Mitochondrial dysfunctions; Parkinson’s disease.

MeSH terms

  • Autophagy / drug effects
  • Cell Line, Tumor
  • Exosomes / drug effects
  • Exosomes / metabolism*
  • Humans
  • Lysosomes / drug effects
  • Lysosomes / metabolism*
  • Mitochondria / drug effects
  • Mitochondria / metabolism*
  • Mitochondria / pathology
  • Parkinson Disease / metabolism*
  • Parkinson Disease / pathology*
  • Sirolimus / pharmacology
  • Stress, Physiological* / drug effects

Substances

  • Sirolimus